€66.40
1.45%
Brüssel, Sep 18, 05:35 pm CEST. Closed.
ISIN
BE0165385973
Symbol
MELE
Index

Melexis Target price 2026 - Analyst rating & recommendation

Melexis Classifications & Recommendation

Buy
47%
Hold
42%
Sell
11%

Melexis Price Target

Target Price €76.50
Price €66.40
Potential
Number of Estimates 15
15 Analysts have issued a price target Melexis 2027 . The average Melexis target price is €76.50. This is higher than the current stock price. The highest price target is
€101.85 53.39%
register free of charge
, the lowest is .
A rating was issued by 19 analysts: 9 Analysts recommend Melexis to buy, 8 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Melexis stock has an average upside potential 2027 of . Most analysts recommend the Melexis stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million € 839.62 886.65
9.99% 5.60%
EBITDA Margin 19.15% 23.52%
26.58% 22.83%

16 Analysts have issued a sales forecast Melexis 2026 . The average Melexis sales estimate is

€887m
unlock
. This is
4.44% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€921m 8.52%
unlock
, the lowest is
€838m 1.29%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 €840m 9.99%
2026
€887m 5.60%
unlock
2027
€972m 9.60%
unlock
2028
€1.1b 9.29%
unlock
2029
€1.2b 9.60%
unlock
2030
€1.2b 3.52%
unlock
2031
€1.3b 5.23%
unlock
2032
€1.4b 13.33%
unlock
2033
€1.6b 9.67%
unlock

16 Analysts have issued an Melexis EBITDA forecast 2026. The average Melexis EBITDA estimate is

€209m
unlock
. This is
7.69% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€221m 14.37%
unlock
, the lowest is
€187m 3.53%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 €161m 33.92%
2026
€209m 29.68%
unlock
2027
€253m 21.50%
unlock
2028
€296m 16.74%
unlock
2029
€348m 17.67%
unlock
2030
€347m 0.22%
unlock
2031
€293m 15.63%
unlock
2032
€455m 55.40%
unlock
2033
€533m 17.13%
unlock

EBITDA Margin

2025 19.15% 26.58%
2026
23.52% 22.83%
unlock
2027
26.07% 10.84%
unlock
2028
27.85% 6.83%
unlock
2029
29.90% 7.36%
unlock
2030
28.82% 3.61%
unlock
2031
23.10% 19.85%
unlock
2032
31.68% 37.14%
unlock
2033
33.83% 6.79%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share 2.78 3.02
34.59% 8.63%
P/E 22.02
EV/Sales 3.31

16 Analysts have issued a Melexis forecast for earnings per share. The average Melexis EPS is

€3.02
unlock
. This is
17.97% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
€3.24 26.56%
unlock
, the lowest is
€2.70 5.47%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 €2.78 34.59%
2026
€3.02 8.63%
unlock
2027
€3.95 30.79%
unlock
2028
€4.74 20.00%
unlock
2029
€5.73 20.89%
unlock
2030
€5.69 0.70%
unlock
2031
€4.64 18.45%
unlock
2032
€7.70 65.95%
unlock
2033
€9.10 18.18%
unlock

P/E ratio

Current 25.94 29.79%
2026
22.02 15.10%
unlock
2027
16.81 23.66%
unlock
2028
14.02 16.60%
unlock
2029
11.58 17.40%
unlock
2030
11.66 0.69%
unlock
2031
14.32 22.81%
unlock
2032
8.62 39.80%
unlock
2033
7.30 15.31%
unlock

Based on analysts' sales estimates for 2026, the Melexis stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.45
2026
3.31 4.16%
unlock
2027
3.02 8.76%
unlock
2028
2.76 8.50%
unlock
2029
2.52 8.76%
unlock
2030
2.43 3.40%
unlock
2031
2.31 4.97%
unlock
2032
2.04 11.76%
unlock
2033
1.86 8.82%
unlock

P/S ratio

Current 3.11 1.16%
2026
2.98 4.25%
unlock
2027
2.72 8.76%
unlock
2028
2.49 8.50%
unlock
2029
2.27 8.76%
unlock
2030
2.19 3.40%
unlock
2031
2.09 4.97%
unlock
2032
1.84 11.76%
unlock
2033
1.68 8.82%
unlock

Current Melexis Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JEFFERIES
Locked
Locked
Locked Jul 01 2026
ODDO BHF
Locked
Locked
Locked Jun 22 2026
ING FM
Locked
Locked
Locked Jun 21 2026
BERENBERG
Locked
Locked
Locked May 07 2026
DEGROOF PETERCAM
Locked
Locked
Locked Feb 23 2026
DEGROOF PETERCAM
Locked
Locked
Locked Feb 22 2026
BERENBERG
Locked
Locked
Locked Feb 17 2026
Analyst Rating Date
Locked
JEFFERIES:
Locked
Locked
Jul 01 2026
Locked
ODDO BHF:
Locked
Locked
Jun 22 2026
Locked
ING FM:
Locked
Locked
Jun 21 2026
Locked
BERENBERG:
Locked
Locked
May 07 2026
Locked
DEGROOF PETERCAM:
Locked
Locked
Feb 23 2026
Locked
DEGROOF PETERCAM:
Locked
Locked
Feb 22 2026
Locked
BERENBERG:
Locked
Locked
Feb 17 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today